Organigram's stock has declined significantly, but my bullish outlook remains due to strong fundamentals, strategic investments, and potential acquisition by British American Tobacco. The company ...
TORONTO, March 03, 2025--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis ...
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.14 per share a year ago. These figures are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback